Login to Your Account



Lifemine lands $55M series A to 'hack' evolution in drug discovery quest

By Marie Powers
News Editor

Monday, September 18, 2017

Startup Lifemine Therapeutics Inc. followed up its $5 million seed round, quietly raised last year, with a $55 million series A led by Wuxi Healthcare Ventures.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription